Morningstar (MORN) Receives a Buy from UBS
In a report released yesterday, Alex Kramm from UBS maintained a Buy rating on Morningstar, with a price target of $280.00.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kramm covers the Financial sector, focusing on stocks such as Cboe Global Markets, CME Group, and Marketaxess Holdings. According to TipRanks, Kramm has an average return of 10.3% and a 60.16% success rate on recommended stocks.
In addition to UBS, Morningstar also received a Buy from TipRanks – PerPlexity’s PerPlexity Financial – Data and Stock Exchanges in a report issued today. However, on the same day, TipRanks – xAI downgraded Morningstar (NASDAQ: MORN) to a Hold.
Based on Morningstar’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $641.1 million and a net profit of $115.1 million. In comparison, last year the company earned a revenue of $591 million and had a net profit of $116.9 million
Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of MORN in relation to earlier this year.
Read More on MORN:
Disclaimer & DisclosureReport an Issue
- PitchBook launches Pioneer certification program to public
- Morningstar announces expanded availability of investment data on Snowflake
- Morningstar: AI-Driven Data Moat and Margin Upside Support Buy Rating
- Morningstar Highlights AI Moat in Latest Investor Q&A
- Morningstar Maintains Quarterly Dividend, Signals Ongoing Stability
